Clinical outcomes of Xen45 gel stent implantatio
Not Applicable
Active, not recruiting
- Conditions
- Diseases of the eye and adnexa
- Registration Number
- KCT0007873
- Lead Sponsor
- Pusan National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
(1) Patients with OAG who underwent ab externo Xen45 gel stent implantation with open conjunctiva approach at the Department of Ophthalmology, Pusan National University Hospital
(2) Patients were followed up for at least 12 months postoperatively.
(3) If both eyes had Xen45 gel stent implantation, the first eye underwent surgery was included.
Exclusion Criteria
(1) Patients who had secondary glaucoma, neovascular glaucoma (except pseudoexfoliation glaucoma, pigmentary glaucoma)
(2) previous glaucoma surgery history (except uncomplicated cataract extraction)
(3) neurological disease, or retinal disease that could affect the visual field or alter the optic nerve.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Kaplan–Meier’s survival analyses were used to evaluate the success rate according to the criterion. The prognostic factors of surgical failure were evaluated using Cox’s proportional hazard regression analysis with enter method.
- Secondary Outcome Measures
Name Time Method pre- and postoperative intraocular pressure/number of glaucoma medication/best corrected visual acuity, bleb morphology, postoperative complications